| Patented Medicine Prices Review Board Canada | news releases
New report shows that high-cost specialty medicines account for an ever-increasing proportion of new treatments coming to market
| Patented Medicine Prices Review Board Canada | news releases
The PMPRB is holding public consultations on its proposed new pricing Guidelines
| Patented Medicine Prices Review Board Canada | news releases
Expenditures on drugs in public plans have increased by an average of 6.6% annually since 2014-15
| Patented Medicine Prices Review Board Canada | news releases
Latest agreement between public payers and the Canadian generic industry closes gap with international prices
| Patented Medicine Prices Review Board Canada | statements
Patented Medicine Prices Review Board (PMPRB) Chairperson Dr. Mitchell Levine made the following statement regarding Health Canada’s final amendments to the Patented Medicines Regulations, which were announced today
| Patented Medicine Prices Review Board Canada | news releases
The Patented Medicine Prices Review Board (PMPRB), through the National Prescription Drug Utilization Information System (NPDUIS) research initiative, today published the 2018 edition of Meds Pipeline Monitor.
| Patented Medicine Prices Review Board Canada | news releases
The Patented Medicine Prices Review Board (PMPRB), through the National Prescription Drug Utilization Information System (NPDUIS) research initiative, today published the 2017 edition of Meds Entry Watch, an annual publication that provides the latest information on new medicines entering Canadian and international markets.
| Patented Medicine Prices Review Board Canada | news releases
The Patented Medicine Prices Review Board will hold a public hearing in the matter of the price of the patented medicine cysteamine bitartrate, sold under the trade name “Procysbi” by the patentee Horizon Therapeutics Canada.
| Patented Medicine Prices Review Board Canada | news releases
Canadian per capita use and spending on drugs for chronic retinal diseases among the highest in the OECD
| Patented Medicine Prices Review Board Canada | news releases
Patented Medicine Prices Review Board seeks applicants for Vice-Chairperson and Board member positions
